Treatment of Post-Polio Syndrome with gamma-globulin

Details Treatment of Post-Polio Syndrome with gamma-globulin Treatment of Post-Polio Syndrome with gamma-globulin

1999-04-01

2000-06-06

Saunders, David

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

4241591, 5303894, A61K 3942, A61K 39395, C07K 1600

Patent

active

060715162

ABSTRACT:
A method for treating a patient suffering from Post-Polio Syndrome (PPS) comprises the intravenous, intramuscular or subcutaneous administration of a pharmacologically effective amount of an immunomodulating agent, in particular gamma-globulin. Also disclosed is the use of the immunomodulating agent for the manufacture of a corresponding medicament, and a pharmaceutical composition for treatment of PPS comprising gamma-globulin.

REFERENCES:
Stiehm, RE Pediatrics 63:301-319, 1979.
Dwyer, N.E. Journal of Medicine 326:107-116, 1992.
Annonymous, Health after 50, Johns Hopkins Newsletter, JHMI, Baltimore MD, p. 8, 1999.
Dinsmore, S. et al. Annals of the NY Academy of Sciences 753:303-313, 1995.
Salazar-Gruezo et al., Comprehensive Therapy 16:24-30, 1990.

Affiliated with

Also associated with

Rating

Treatment of Post-Polio Syndrome with gamma-globulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of Post-Polio Syndrome with gamma-globulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Post-Polio Syndrome with gamma-globulin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2211190